Potential Consequences for the International Financial Markets
During the current GATS negotiations on liberalising financial services, the benefits of a strengthened financial system have been highlighted, while the risks of increased instability have been underestimated, especially by the Northern countries. This paper has identified several ways in which liberalisation of financial services can contribute to financial instability. In order to address this increased risk of instability, an appropriate regulatory and supervisory framework for banking, insurance and securities is required. Developing countries often lack the capacity and resources for such necessary safeguards. Therefore there should be much more open public and political discussions linking the degree of liberalisation requested by the EU and the degree of regulation and supervision already in place to deal with new financial service providers and their services. No commitments should be made in this area during the bilateral GATS negotiations, unless there is full guarantee by both sides that the necessary safeguards are in place, nor should the EU insist on any such commitments. read more lessrelated content
How Big Tech is becoming the Government
Get in touch and find out what SOMO Services can do for you
read moreWill a new EU law help to achieve the climate change targets?
In order to meet the climate targets of the Paris Agreement and encourage more environmentally friendly investments, a new EU law establishes clear EU definitions of what ‘green’ actually is. This EU Taxonomy Regulation wants…
The EU taxonomy
Time to start caring about cobalt
Large insurers do not tackle abuse in cobalt mining
The nine largest insurance groups in the Netherlands (Achmea, Aegon, Allianz, ASR, CZ, Menzis, NN Group, VGZ and Vivat) do not do enough to prevent or tackle serious human rights violations in the cobalt sector….
Crash Course
A new webinar series entitled ‘Crash Course’ will be launched in the second week of June. SOMO is one of the partners in this platform that is designed to open up debate on how we…
The earnings model of the pharmaceutical industry needs to be overhauled
We Can’t Afford Big Pharma’s Greed
Private gains we can ill afford
SOMO reveals the financialisation of the pharmaceutical industry and the potentially deadly costs
Research by SOMO into the world’s 27 largest pharmaceutical companies shows that over the past eighteen years, the sector has shifted its focus from being a pharmaceutical producer to an investment industry. The research undermines…